Substance Dependence Satisfaction With Care and Quality Of Life (SUBUSQOL)

September 5, 2016 updated by: Central Hospital, Nancy, France

Satisfaction With Care and Quality of Life in Subjects With Substance Dependence

The SUBUSQOL cohort aimed to improve knowledge of the quality of ambulatory care, in particular the prognostic role of the early satisfaction with care on the change from baseline quality of self-reported health status in outpatients with alcohol or opioid dependence. It is a multicenter prospective cohort. Satisfaction was assessed using a multidimensional self-administered and validated questionnaire during the early care process. In addition to measuring satisfaction and obtaining sociodemographic and clinical data, this study collected data on the self-reported health status at inclusion and 3, 6 and 12 months after inclusion.

Study Overview

Status

Unknown

Conditions

Detailed Description

Early satisfaction with care was measured using the quality of care satisfaction questionnaire in outpatient consultation (EQS-C). Data collected during the study included patient sociodemographic, clinical and health status characteristics, as well as physician characteristics. Self-perceived quality of life was assessed using the generic SF-12 and a specific questionnaire in illness disease, the Quality of Life Enjoyment and Satisfaction Questionnaire-Short Form (Q-LES-Q-SF).

Study Type

Observational

Enrollment (Anticipated)

600

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • France
      • Jury-les-Metz, France, 57073
        • Recruiting
        • CHS (Hospital of Jury-les-Metz)
        • Contact:
          • Olivier POUCLET
          • Phone Number: 03 87 56 39 60
        • Sub-Investigator:
          • Olivier POUCLET
      • Nancy, France, 54000
        • Recruiting
        • CSAPA (Healthcare Center of Accompaniment and Prevention in Addictology), University Hospital of Nancy
        • Contact:
        • Sub-Investigator:
          • Raymund Schwan, Pr
      • Saint-Flour, France, 15100
        • Recruiting
        • ANPAA 15- CSAPA (Healthcare Center of Accompaniment and Prevention in Addictology)
        • Contact:
          • Alex BEDES
          • Phone Number: 04 71 60 16 85

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Outpatients with substance dependence

Description

Inclusion Criteria:

  • Outpatients who met the Diagnostic and Statistical Manual, fourth edition (DSM-IV) criteria for alcohol dependence, opioid dependence, or both.
  • Patients recruited from the French specialized addiction treatment centers where they began care.
  • Patient agreement obtained

Exclusion Criteria:

  • Age lower than 18 years
  • Inability to complete self-questionnaires

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality of life score
Time Frame: Change from inclusion at 12 months
Self-perceived quality of life score using the Short-Form 12 questionnaire (SF-12)
Change from inclusion at 12 months
Quality of life score
Time Frame: Change from inclusion at 12 months
Self-perceived quality of life score using the Quality of life enjoyment and satisfaction questionnaire short form (Q-LES-Q-SF)
Change from inclusion at 12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Care satisfaction
Time Frame: 15 and 45 days after inclusion
Outpatient satisfaction score using the quality of care satisfaction questionnaire in outpatient consultation (EQS-C)
15 and 45 days after inclusion

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Central Hospital, Nancy, France

Collaborators

Hospital of Jury-les-Metz, France
Healthcare Center of Accompaniment and Prevention in Addictology, Saint-Flour, France

Investigators

  • Principal Investigator: Cédric Baumann, PhD, CHRU Nancy, PARC

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2014

Primary Completion (Anticipated)

March 1, 2017

Study Completion (Anticipated)

March 1, 2018

Study Registration Dates

First Submitted

August 26, 2016

First Submitted That Met QC Criteria

September 5, 2016

First Posted (Estimate)

September 9, 2016

Study Record Updates

Last Update Posted (Estimate)

September 9, 2016

Last Update Submitted That Met QC Criteria

September 5, 2016

Last Verified

September 1, 2016

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • SUBUSQOL

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Alcoholism

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Rwanda

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe